Canada’s PREVENT Consortium Names Board Members
Canada’s Pan-Provincial Vaccine Enterprise, or PREVENT, consortium has named nine scientists to its board of directors:
- Lorne Babiuk (Chair), vice president of research, University of Alberta;
- Christian Blouin, director of the vaccine division at Merck Frosst Canada;
- Robert Brunham, provincial executive director for the BC Center for Disease Control;
- Richard Florizone, vice president of finance and resources at the University of Saskatchewan;
- Scott Halperin, director of the Canadian Center for Vaccinology;
- Gregory Hammond, director of the Public Health Branch for the Province of Manitoba;
- George Khachatourians, a professor at the University of Saskatchewan;
- David Scheifele, professor of pediatrics in the division of immunology and infectious diseases at the University of British Columbia; and
- Andrew Potter, director of the University of Saskatchewan’s International Vaccine Center
PREVENT’s goal is to accelerate the commercialization of Canadian vaccine discoveries “and overcome hurdles that currently hamper development of new and safer vaccines," said Andrew Potter, PREVENT's chief executive officer and head of the Vaccine and Infectious Disease Organization at the University of Saskatchewan, where PREVENT will be housed.
Diabetes Research Institute to Honor Realtor Tom Silver
Tom Silver, president of Orda Management Corporation, will be honored at the Diabetes Research Institute’s D.R.E.a.M.S. in the City event on May 14.
Silver, who will receive the DRI’s Dare to Dream award, has been living with type 1 diabetes for more than 30 years, and a “vigorous supporter” of the DRI, the organization said.
Silver is a Northeast Regional Board member of the Diabetes Research Institute Foundation, and his wife, Natasha Silver, is honorary chair of D.R.E.a.M.S. in the City.